Physician

Mugdha Agrawal, M.D.

According to 2025 Medicare claims, Mugdha Agrawal, M.D. (NPI: 1144595414) practices rheumatology in the Camden, NJ market, with the plurality of this provider's patient population coming from Burlington, NJ. This provider's primary affiliated billing organization is TRABECULAR MEDICAL GROUP, LLC (NPI: 1427622661; TIN: 851604336) and primary practice location at 08043-1559. Agrawal is affiliated with the Mercy Health Select, LLC (ACO ID: A1215) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Agrawal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 741 traditional Medicare patients, billed 128,008 HCPCS/CPT codes, and received $1,542,615 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,053 prescription claims across 297 beneficiaries totaling $361,226 in drug costs, led by Cosentyx Sensoready (2 Pens) (Secukinumab). Open Payments data shows 35 records totaling $7,929. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $7,769 to $1,542,615. Similarly, Part D prescription costs have risen steadily, from $15,914 to $361,226. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	50	52	$7,769
2016	37	38	$4,256
2017	N/R	N/R	N/R
2018	36	57	$5,591
2019	111	246	$20,918
2020	174	4,899	$80,058
2021	386	34,773	$690,063
2022	422	46,229	$779,825
2023	376	44,468	$626,112
2024	741	128,008	$1,542,615

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	36	155	$15,914
2016	19	57	$5,706
2017	19	159	$18,856
2018	40	201	$92,984
2019	116	525	$272,223
2020	133	566	$487,829
2021	207	652	$63,900
2022	253	924	$91,928
2023	218	714	$124,043
2024	297	1,053	$361,226

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	165	290	$118
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	321	578	$106
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	159	286	$65
J0897	Injection, denosumab, 1 mg	111	8,460	$21
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	218	382	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cosentyx Sensoready (2 Pens)	Secukinumab	14	392	$99,359
Humira(Cf)	Adalimumab	12	336	$80,048
Methotrexate	Methotrexate Sodium	182	11,356	$5,245
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	81	6,540	$4,239
Leflunomide	Leflunomide	54	3,472	$2,576

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	34	$920	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$7,009	E.R. Squibb & Sons, L.L.C.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mugdha Agrawal, M.D.?

Tedicare shows public-source Medicare data for Mugdha Agrawal, M.D. (NPI 1144595414), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mugdha Agrawal, M.D. have ACO affiliation data?

Mugdha Agrawal, M.D. is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Mugdha Agrawal, M.D.?

Mugdha Agrawal, M.D. is linked to TRABECULAR MEDICAL GROUP, LLC (billing NPI 1427622661) in the available physician profile data.

Does Mugdha Agrawal, M.D. have Open Payments data?

Mugdha Agrawal, M.D. has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.